re: bullish report Interesting that Ozequities Newsletter has...

re: bullish report Interesting that Ozequities Newsletter has just released a very bullish report on Solagran which begins as follows:

FEATURE
Week's Special

SOLAGRAN: FLAGSHIP NATURALLY DERIVED LIVER CURE PRODUCT WELL ON THE WAY TO COMMERCIALISATION
By Jenny Prabhu and Gerald Stanley


There has been only one other company, Sirtex (our first report on SRX was when it traded at 56c), in the 18 years or so of Weekly Specials where we have felt inspired to write a follow up report in less than a year from the first.

Solagran is at present little known and even less understood..."